Related Experiment Videos
Nephrotic syndrome associated with methimazole therapy.
Archives of Internal Medicine
|February 1, 1979
Summary
Methimazole, used for hyperthyroidism, can cause nephrotic syndrome. This case report suggests methimazole acts as a direct kidney toxin, leading to proteinuria that resolves upon drug withdrawal.
Area of Science:
- Endocrinology
- Nephrology
- Pharmacology
Background:
- Thionamide medications are standard treatments for hyperthyroidism.
- Adverse reactions to thionamides are uncommon.
- Graves' disease is a common cause of hyperthyroidism.
Observation:
- A young man with Graves' disease developed nephrotic syndrome while on methimazole therapy.
- The patient experienced significant proteinuria.
- Renal biopsy revealed histological similarities to puromycin aminonucleoside-induced toxic nephrosis.
Findings:
- Methimazole therapy was associated with the development of nephrotic syndrome.
- Proteinuria resolved rapidly after discontinuing methimazole.
- Histological findings suggest a direct nephrotoxic effect of methimazole on glomeruli.
Implications:
- Methimazole may act as a direct glomerular toxin.
- This mechanism could explain drug-induced nephrotic syndrome in susceptible individuals.
- Clinicians should consider methimazole toxicity in patients with unexplained nephrotic syndrome.